A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
← catalyst calendarSponsored by Krystal Biotech, Inc. (industry) · KRYS — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
40estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-08-02 | actual | When the study began enrolling |
| Primary completion | Dec 2025 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2025 | estimated | The whole study's end, after follow-up |
| First posted | 2024-08-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-07-02 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Epidermolysis Bullosa Dystrophica
- Epidermolysis Bullosa Dystrophica, Recessive
- Epidermolysis Bullosa Dystrophica Dominans
Primary outcome
what the primary-completion date above is the date OFCorneal abrasion frequency
measured Baseline through up to 1 year
Permalink · KRYS's whole pipeline · Catalyst calendar · Every registered study · What changed